These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35352192)

  • 1. Hypervitaminosis D and nephrocalcinosis: too much of a good thing?
    Wan M; Patel J; Rait G; Shroff R
    Pediatr Nephrol; 2022 Oct; 37(10):2225-2229. PubMed ID: 35352192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypervitaminosis D. Review of fifteen cases].
    Castelló F; Callís L; Nieto JL; Vilaplana E
    An Esp Pediatr; 1979 Mar; 12(3):207-18. PubMed ID: 443641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [VITAMIN D INTOXICATION, HYPERCALCEMIA AND NEPHROCALCINOSIS].
    LESSARD R; LABRIE F; BEAUDET M
    Laval Med; 1963 Nov; 34():1070-80. PubMed ID: 14096791
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of iatrogenic vitamin D toxicity revealed by drug reconciliation.
    Mouton Sclaunich H; Marchand C; Rekik A; Chenailler C; Varin R; Doucet J
    Therapie; 2022; 77(3):388-390. PubMed ID: 34454745
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypervitaminosis D.--A case report.
    Taylor FE
    Med Times; 1966 Nov; 94(11):1275-9. PubMed ID: 5922345
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis.
    Atabek ME; Pirgon O; Sert A
    J Pediatr Endocrinol Metab; 2006 Feb; 19(2):169-72. PubMed ID: 16562591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bisphosphonate therapy for vitamin D intoxication of the infant.
    Bereket A; Erdogan T
    Pediatrics; 2003 Apr; 111(4 Pt 1):899-901. PubMed ID: 12671131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ultrastructural study of glomerular alterations in hypervitaminosis D. Apropos of 5 cases].
    Fabre MT; Fabre J; Barthe P; Yacoubi B; Régnier C
    J Urol Nephrol (Paris); 1968 Dec; 74(12):982-9. PubMed ID: 5714751
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrocalcinosis in children who received high-dose vitamin D.
    Lin TH; Lu HJ; Lin CH; Lee MD; Chang BP; Lin CC; Tsai JD
    Pediatr Nephrol; 2022 Oct; 37(10):2471-2478. PubMed ID: 35352189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia and hypervitaminosis D.
    REED CI
    Fed Proc; 1947; 6(1 Pt 2):185. PubMed ID: 20342826
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypercalcemia, hypervitaminosis A and 3-epi-25-OH-D3 levels after consumption of an "over the counter" vitamin D remedy. a case report.
    Granado-Lorencio F; Rubio E; Blanco-Navarro I; Pérez-Sacristán B; Rodríguez-Pena R; García López FJ
    Food Chem Toxicol; 2012 Jun; 50(6):2106-8. PubMed ID: 22426357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature.
    Vogiatzi MG; Jacobson-Dickman E; DeBoer MD;
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1132-41. PubMed ID: 24456284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of hypercalcemia Indications for 1,25-dihydroxyvitamin D prescription.
    Malandain D; Roussey G; Leloupp AG; Graveline N; Masson D; Bach-Ngohou K
    Ann Biol Clin (Paris); 2015; 73(5):573-80. PubMed ID: 26489816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hypervitaminosis D-induced hypercalcaemia treated with glucocorticoids and bisphosphonates.
    Houghton CC; Lew SQ
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32354763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vitamin D supplementation: not too much, not too little!].
    Hamo S; Freychet C; Bertholet-Thomas A; Poulat AL; Cochat P; Vuillerot C; Bacchetta J
    Arch Pediatr; 2015 Aug; 22(8):868-71. PubMed ID: 26141804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypervitaminosis D due to a dietary supplement].
    Zigenhorn M; Westerman EM; Rietveld AP
    Ned Tijdschr Geneeskd; 2016; 160():A9360. PubMed ID: 27071359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-dependent Hypercalcemia.
    Schlingmann KP
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):729-742. PubMed ID: 34774244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypercalcaemia due to hypervitaminosis D.
    Premawardena C; Kumar S; Yao Tan C
    Intern Med J; 2021 Mar; 51(3):456-457. PubMed ID: 33738940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.